Search contract descriptions, companies and agencies.
ADDITION OF NEW ANTIVIRAL / THERAPEUTIC ASSET FOR 2019 NOVEL CORONAVIRUS (COVID-19)
Total Committed
$690M
Product or Service Description
Drugs and Biologicals
Total Potential Value
$1.23B
Contracting Agency
Effective Date
Aug. 15, 2017
Funding Department
OFFICE OF ACQ MGMT POLICY
Type
Cost sharing
Solicitation Procedure
Negotiated proposal/quote
Extent Competed
Full and open competition
Recent Contract Actions 
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Vendor | Description | Signed | Reason for Change | Amount Committed |
|---|---|---|---|---|
| JANSSEN PHARMACEUTICALS INC | THIS AMENDMENT 12 AGREEMENT MAKES BILATERAL CHANGES WITHIN THE GENERAL SCOPE OF THIS AGREEMENT TO (I) RELINQUISH USG'S OWNERSHIP INTEREST IN 150,000 VIALS OF AD26.COV2.S VACCINE CONTAINING 2X1011 VP / ML (EQUIVALENT TO 300,000 5X1010 VP VA | Feb. 11, 2021 | Other Administrative Action | $0 |
| JANSSEN PHARMACEUTICALS INC | THIS AMENDMENT, BASED ON JOINT OVERSIGHT COMMITTEE (JOC) RECOMMENDATION, DOCUMENTED IN MEMO #12 DATED 16 JUNE 2020, AND IN ACCORDANCE WITH ARTICLE IV OF THE OTA, ADDS (I) A NON-HUMAN PRIMATE (NHP) WITHIN WORK PACKAGE (WP) 6.2, (II) ADDS A RANDOMIZED, | Aug. 20, 2020 | Change Order | $85,304,775 |
| JANSSEN PHARMACEUTICALS INC | ADDITION OF NEW VACCINE ASSET FOR 2019 NOVEL CORONAVIRUS (COVID-19) | March 27, 2020 | Supplemental Agreement For Work Within Scope | $456,237,081 |
| JANSSEN PHARMACEUTICALS INC | ADDITION OF NEW ANTIVIRAL / THERAPEUTIC ASSET FOR 2019 NOVEL CORONAVIRUS (COVID-19) | March 20, 2020 | Supplemental Agreement For Work Within Scope | $148,373,126 |
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.